Aelis Farma Statistics

Total Valuation

Aelis Farma has a market cap or net worth of EUR 13.19 million. The enterprise value is 5.22 million.

Market Cap	13.19M
Enterprise Value	5.22M

Important Dates

The next estimated earnings date is Monday, September 22, 2025.

Earnings Date	Sep 22, 2025
Ex-Dividend Date	n/a

Share Statistics

Aelis Farma has 13.59 million shares outstanding. The number of shares has increased by 4.22% in one year.

Current Share Class	13.59M
Shares Outstanding	13.59M
Shares Change (YoY)	+4.22%
Shares Change (QoQ)	+3.32%
Owned by Insiders (%)	38.34%
Owned by Institutions (%)	n/a
Float	3.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.37
PB Ratio	1.30
P/TBV Ratio	1.33
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-0.70
EV / Sales	0.94
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-0.43

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.60.

Current Ratio	3.77
Quick Ratio	3.44
Debt / Equity	0.60
Debt / EBITDA	n/a
Debt / FCF	-0.51
Interest Coverage	-34.39

Financial Efficiency

Return on equity (ROE) is -63.95% and return on invested capital (ROIC) is -28.92%.

Return on Equity (ROE)	-63.95%
Return on Assets (ROA)	-21.03%
Return on Invested Capital (ROIC)	-28.92%
Return on Capital Employed (ROCE)	-51.93%
Revenue Per Employee	198,643
Profits Per Employee	-266,286
Employee Count	28
Asset Turnover	0.24
Inventory Turnover	n/a

Taxes

In the past 12 months, Aelis Farma has paid 8,000 in taxes.

Income Tax	8,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -92.11% in the last 52 weeks. The beta is 0.59, so Aelis Farma's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-92.11%
50-Day Moving Average	1.16
200-Day Moving Average	2.16
Relative Strength Index (RSI)	35.85
Average Volume (20 Days)	20,424

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aelis Farma had revenue of EUR 5.56 million and -7.46 million in losses. Loss per share was -0.55.

Revenue	5.56M
Gross Profit	5.56M
Operating Income	-7.74M
Pretax Income	-7.45M
Net Income	-7.46M
EBITDA	-7.65M
EBIT	-7.74M
Loss Per Share	-0.55

Full Income Statement

Balance Sheet

The company has 14.05 million in cash and 6.08 million in debt, giving a net cash position of 7.97 million or 0.59 per share.

Cash & Cash Equivalents	14.05M
Total Debt	6.08M
Net Cash	7.97M
Net Cash Per Share	0.59
Equity (Book Value)	10.12M
Book Value Per Share	0.74
Working Capital	13.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -11.83 million and capital expenditures -190,000, giving a free cash flow of -12.02 million.

Operating Cash Flow	-11.83M
Capital Expenditures	-190,000
Free Cash Flow	-12.02M
FCF Per Share	-0.88

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -139.12% and -134.05%.

Gross Margin	100.00%
Operating Margin	-139.12%
Pretax Margin	-133.91%
Profit Margin	-134.05%
EBITDA Margin	-137.59%
EBIT Margin	-139.12%
FCF Margin	n/a

Dividends & Yields

Aelis Farma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.22%
Shareholder Yield	n/a
Earnings Yield	-56.55%
FCF Yield	-91.17%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1